Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2025
Thirty years' experience with immediate-type local anesthetic hypersensitivity reactions in children.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ocak Melike, Bal Çetinkaya Fatma, Akarsu Ayşegül, İlgün Gürel Deniz, Ünsal Hilal, Soyak Aytekin Elif, Sahiner Umit Murat, Sekerel Bulent Enis, Soyer Ozge
Аннотация
BACKGROUND: The literature includes scarce data on pediatric local anesthetics (LA) allergy and its diagnostic test results.
OBJECTIVE: This study aimed to determine the prevalence of true LA allergy over 30 years.
METHOD: We evaluated clinical data and test results of patients with suspected immediate-type LA allergy.
RESULTS: This study group consisted of 231 children with a median (interquartile-range) age of 9.1 years (6.5-12.9), with a male predominance (57.6%). The majority of reactions occurred during the dental procedures (84.8%). The most common presenting symptoms were mucocutaneous system reactions in 208 patients (90%). A total of 250 SPTs were performed in all 231 patients with the following drugs: Articaine n = 73 (29.2%), Lidocaine n = 71 (28.4%), Prilocaine n = 65 (26%), and Mepivacaine n = 40 (16%). Local anesthetic allergy was confirmed by positive skin tests (1 SPT, 9 IDT) in 10 patients (4.3%), including 8 patients with one LA and 2 patients with two LAs. In patients with true LA allergy, the median age of the reaction was significantly lower (p = .004), whereas the rate of anaphylaxis was found to be higher (p < .001). Multivariate analysis suggested that a symptom of urticaria (OR: 21.724 [95% CI: 3.349-140.934], p = .001, VIF = 1.074), a history of anaphylaxis (OR: 40.690 [95% CI: 5.877-281.747], p < .001, VIF = 1.056), testing with articaine (OR: 34.559 [95% CI: 3.846-310.507], p = .002, VIF = 1.010), and family history of atopy (OR: 9.410 [95% CI: 1.438-61.593], p = .019, VIF = 1.027) were potential risk factors for true LA allergy, although these findings should be interpreted with caution due to the limited number of cases.
CONCLUSION: True LA allergy was detected in 4.3% of patients, slightly higher than reported in the literature. This may be due to our center being a regional referral center and the study population including immediate-type reactions. Despite the widespread use of LA, IgE-mediated allergy is less common than expected but not rare.
OBJECTIVE: This study aimed to determine the prevalence of true LA allergy over 30 years.
METHOD: We evaluated clinical data and test results of patients with suspected immediate-type LA allergy.
RESULTS: This study group consisted of 231 children with a median (interquartile-range) age of 9.1 years (6.5-12.9), with a male predominance (57.6%). The majority of reactions occurred during the dental procedures (84.8%). The most common presenting symptoms were mucocutaneous system reactions in 208 patients (90%). A total of 250 SPTs were performed in all 231 patients with the following drugs: Articaine n = 73 (29.2%), Lidocaine n = 71 (28.4%), Prilocaine n = 65 (26%), and Mepivacaine n = 40 (16%). Local anesthetic allergy was confirmed by positive skin tests (1 SPT, 9 IDT) in 10 patients (4.3%), including 8 patients with one LA and 2 patients with two LAs. In patients with true LA allergy, the median age of the reaction was significantly lower (p = .004), whereas the rate of anaphylaxis was found to be higher (p < .001). Multivariate analysis suggested that a symptom of urticaria (OR: 21.724 [95% CI: 3.349-140.934], p = .001, VIF = 1.074), a history of anaphylaxis (OR: 40.690 [95% CI: 5.877-281.747], p < .001, VIF = 1.056), testing with articaine (OR: 34.559 [95% CI: 3.846-310.507], p = .002, VIF = 1.010), and family history of atopy (OR: 9.410 [95% CI: 1.438-61.593], p = .019, VIF = 1.027) were potential risk factors for true LA allergy, although these findings should be interpreted with caution due to the limited number of cases.
CONCLUSION: True LA allergy was detected in 4.3% of patients, slightly higher than reported in the literature. This may be due to our center being a regional referral center and the study population including immediate-type reactions. Despite the widespread use of LA, IgE-mediated allergy is less common than expected but not rare.